Residual Lesional Gene Expression in Psoriasis Patients with Complete Skin Clearance Treated with Guselkumab or Adalimumab in VOYAGE 1 and 2. J Invest Dermatol 2024 Jun 25
Date
06/28/2024
Pubmed ID
38936766DOI
10.1016/j.jid.2024.05.020Scopus ID
2-s2.0-85199086852 (requires institutional sign-in at Scopus site)
Author List
Blauvelt A, Gordon KB, Langley RG, Branigan PJ, Chen Y, Miller M, Han C, Fakharzadeh S, Muñoz-Elías EJ, Armstrong AW
Author
Kenneth Brian Gordon MD Chair, Professor in the Dermatology department at Medical College of Wisconsin